UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”), a clinical-stage biopharmaceutical company pioneering the discovery and development of peptide-based therapeutics, today announced that ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move. A twice-a-day pill for the most ...

A twice-a-day pill for advanced breast cancer has been approved for use on the NHS. The life-extending drug, called ...

Results from a clinical trial showed that capivasertib plus the hormone therapy fulvestrant increased the time before the ...

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...